Naringenin treatment ameliorates hepatocellular carcinoma in diabetic rats

dc.contributor.authorFouad, Amr A.
dc.contributor.authorAl-Salman, Alaa Adel
dc.contributor.authorAl-Khamis, Ahmad Hussain
dc.contributor.authorAl-Salem, Ali
dc.date.accessioned2024-07-12T21:00:21Z
dc.date.available2024-07-12T21:00:21Z
dc.date.issued2014en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractIt was reported that patients with diabetes mellitus are at higher risk of developing hepatocellular carcinoma (HCC) due to increased oxidative/nitrosative stress and inflammatory reactions.en_US
dc.identifier.citationFouad, A. A., Al-Salman, A. A., Al-Khamis, A. H. ve Al-Salem, A. (2014). Naringenin treatment ameliorates hepatocellular carcinoma in diabetic rats. Frontiers in Medical Sciences: Diabetes, Cancer and Their Connection / Tıpta Yenilikler: Diyabet, Kanser ve İlişkileri, Maltepe Üniversitesi. s. 76.en_US
dc.identifier.endpage77en_US
dc.identifier.startpage76en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3348
dc.language.isoenen_US
dc.publisherMaltepe Üniversitesien_US
dc.relation.ispartofFrontiers in Medical Sciences: Diabetes, Cancer and Their Connection / Tıpta Yenilikler: Diyabet, Kanser ve İlişkilerien_US
dc.relation.publicationcategoryUluslararası Konferans Öğesi - Başka Kurum Yazarıen_US
dc.rightsCC0 1.0 Universal*
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.snmzKY07424
dc.subjectNaringeninen_US
dc.subjectDiabetesen_US
dc.subjectMellitusen_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectRatsen_US
dc.titleNaringenin treatment ameliorates hepatocellular carcinoma in diabetic ratsen_US
dc.typeConference Object
dspace.entity.typePublication

Dosyalar